Breakthroughs in Vitiligo and Alopecia Areata | Frontline Focus | AAD 2026
In this Frontline Focus video, Prof. Brett King shares major advances in vitiligo and alopecia areata presented at the 2026 AAD Annual Meeting. Topics include IL-15 antibody therapy combined with phototherapy for vitiligo, the latest adolescent data on upadacitinib and baricitinib in alopecia areata, emerging non-JAK pathways such as rezpegaldesleukin, and clinical insights on switching between JAK inhibitors.
The discussion highlights the rapidly evolving therapeutic landscape in vitiligo and alopecia areata, providing dermatologists with important updates on efficacy, treatment strategy, and future directions.
The AAD 2026 Special Edition brings together leading dermatology experts and researchers to share key insights and latest developments from the congress.
This content has been developed independently by TalkMED. It is not affiliated with or endorsed by the American Academy of Dermatology (AAD). Views expressed are those of the speakers and do not necessarily reflect the views of TalkMED.
________________________________
About TalkMED Congress Updates
TalkMED Congress Updates (Online ISSN: 3134-7886) is an open-access video journal published by TalkMED, featuring academic summaries, expert interviews, and educational highlights from major international medical congresses. For more information, visit https://journal.talkmed.com.
TalkMED is a medical education platform under eDoctor Healthcare Communications, delivering expert insights, clinical updates, and curated content from leading global medical conferences, serving healthcare professionals worldwide.
All rights reserved by TalkMED.